Work

Epirubicin (E) followed by cyclophosphamide, methotrexate, 5-fluorouracil (CMF) versus paclitaxel (T) followed by epirubicin and vinorelbine (EV) in patients (pts) with high-risk operable breast cancer

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.e11521

Authors: F. Boccardo, A. Rubagotti, P. Guglielmini, P. Sismondi, A. Farris, D. Amadori, B. Agostara, A. Gambi, G. Catalano, M. Faedi

Institutions: University of Sassari, University of Genoa

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2247124384

Cites:

Cited by:

Related to: 10